[BCR/ABL targeted immunotherapy using dendritic cells].
Takahashi
K
K
Hirai
H
H
D003713:Dendritic Cells / Q000276:immunology*; D016044:Fusion Proteins, bcr-abl / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D000922:Immunotoxins / Q000008:administration & dosage; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*
D000922:Immunotoxins; D016044:Fusion Proteins, bcr-abl